What is CVE-2022-26389?

CVE-2022-26389 is a high-severity vulnerability in Baxter/ Hillrom Eli 380 Resting Electrocardiograph, classified under Improper Access Control. CVSS score: 7.7/10. Published 2025-02-07.

How severe is CVE-2022-26389?

High severity. CVSS v3 base score is 7.7 out of 10.

Vulnerability in Baxter/ Hillrom Eli 380 Resting Electrocardiograph

CVE-2022-26389

An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

EPSS: 0.003 (20.4th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.7 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H.

Affected products

Baxter/ Hillrom Eli 380 Resting Electrocardiograph — versions 0
Welch Allyn Eli 150c/bur 150c/mlbur 150c Resting Electrocardiograph — versions 0
Welch Allyn Eli 250c/bur 250c Resting Electrocardiograph — versions 0
Welch Allyn Eli 280/bur280/mlbur 280 Resting Electrocardiograph — versions 0

Weakness classification (CWE)

CWE-284 — Improper Access Control

References

Frequently asked questions

What is CVE-2022-26389?: CVE-2022-26389 is a high-severity vulnerability in Baxter/ Hillrom Eli 380 Resting Electrocardiograph, classified under Improper Access Control. CVSS score: 7.7/10. Published 2025-02-07.
How severe is CVE-2022-26389?: High severity. CVSS v3 base score is 7.7 out of 10.